D715-2151 Screening compound: N-[3-(benzenesulfonyl)-4,5-dimethyl-1-propyl-1H-pyrrol-2-yl]-2H-1,3-benzodioxole-5-carboxamide

D715-2151 Screening compound: N-[3-(benzenesulfonyl)-4,5-dimethyl-1-propyl-1H-pyrrol-2-yl]-2H-1,3-benzodioxole-5-carboxamide
D715-2151 Screening compound: N-[3-(benzenesulfonyl)-4,5-dimethyl-1-propyl-1H-pyrrol-2-yl]-2H-1,3-benzodioxole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D715-2151
N-[3-(benzenesulfonyl)-4,5-dimethyl-1-propyl-1H-pyrrol-2-yl]-2H-1,3-benzodioxole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D715-2151

Molecular Formula

C23H24N2O5S (C23 H24 N2 O5 S)

Compound Name

N-[3-(benzenesulfonyl)-4,5-dimethyl-1-propyl-1H-pyrrol-2-yl]-2H-1,3-benzodioxole-5-carboxamide

IUPAC name

N-[3-(benzenesulfonyl)-45-dimethyl-1-propyl-1H-pyrrol-2-yl]-2H-13-benzodioxole-5-carboxamide

SMILES

CCCn(c(C)c1C)c(NC(c(cc2)cc3c2OCO3)=O)c1S(c1ccccc1)(=O)=O

InChI

InChI=1S/C23H24N2O5S/c1-4-12-25-16(3)15(2)21(31(27,28)18-8-6-5-7-9-18)22(25)24-23(26)17-10-11-19-20(13-17)30-14-29-19/h5-11,13H,4,12,14H2,1-3H3,(H,24,26)

InChI Key

KZYLXNUPFJFTTI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09856635

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.063

Distribution Coefficient, logD

4.051

Water Solubility, LogSw

-3.97

Polar Surface Area

71.565

Acid Dissociation Constant (pKa)

8.94

Base Dissociation Constant (pKb)

-2.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

D715-2151 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Others
  • GPCR
  • Kinases
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D715-2151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D715-2151?
Check Price and Availability of D715-2151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D715-2151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D715-2151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D715-2151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D715-2151 available by request